Professor Dingbo Xu appointed to's board of directors

China’s Inc. has announced that Professor Dingbo Xu, a renowned accounting professor and associate dean at China Europe International Business School (CEIBS), has been elected to serve on the audit committee of its board of directors and as the chairperson of the board's nominating and corporate governance committee. The company added that Xu will replace David Daokui Li who is retiring after having completed his second two-year term on the board since the company's initial public offering in May 2014.

"After a thorough search, we are delighted to have chosen professor Xu to join our board of directors," said Richard Liu, Chairman of's board of directors in a statement, adding, "He has an outstanding reputation and we have complete confidence that he will be an excellent addition to our board as we move into our next phase of development."

Professor Xu has served as a faculty member and professor in recognised universities for more than two decades. He is currently Essilor Chair Professor in accounting and an associate dean at CEIBS in Shanghai. Before joining CEIBS in 2004, he was an assistant professor of accounting at the Hong Kong University of Science and Technology from 1996 to 2003.

In addition to his academic positions, Professor Xu serves as the executive director of the editorial board of China Management Accounting Review, the founding chairman of Charted Global Management Accountant (CGMA) 100 North Asia Leaders Think Tank, and the chairman of the expert panel of China Social Poverty Alleviation Network. further said that professor Xu has contributed his knowledge and expertise to the board of directors of several public companies. He was a member of the board of directors of The People's Insurance Company of China Limited (PICC), a Hong Kong Exchange (HKEx) listed company, from September 2009 to April 2018. He currently serves on the board of directors of China Cinda Asset Management Co. Ltd, a HKEx-listed company, as well as SANY Heavy Industry, Kweichow Moutai Company Limited and Shanghai Shyndec Pharmaceutical Co., Ltd., all of which are listed on the Shanghai Stock Exchange.

" is a highly innovative and forward-looking company, and I am very pleased to join its board," added Xu. media resources


Related news